Skip to contentC
Catheter Precision, Inc.
C
VJETCatheter Precision, Inc. Q2 2025 · 10-Q
Revenue$212.00K$212.00K+128.0% vs Q2 2024 Net Income-$5.11M-$5.11MN/M vs Q2 2024 EPS, diluted—
Gross Profit$198,000+157.1% Operating Income-$4,686,000N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Catheter Precision, Inc. · CIK 1716621 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,263,000N/M Free Cash Flowderived-$2,270,000N/M Margins · derivedGross margin93.4%+10.6 pt vs Q2 2024
Operating margin-2210.4%+711.1 pt vs Q2 2024
Net margin-2409.9%+2127.7 pt vs Q2 2024
ended Jun 30, 2025 · filed Aug 11, 2025 · 42 d after period end